How the new Trade Secret Law affects the healthcare sector. Should I protect my know-how to safeguard my company’s innovation?
With the entry into force of the new Trade Secret Law on March 13th, the concept of trade secret is defined, and the establishment of a series of security measures to protect it is proposed.
In many cases, trade secrets complement the protection granted by patents and, in others, they are the only way to protect certain knowledge generated by the R & D of companies and public entities. In the biotechnology field and in the healthcare sector, it makes it possible for us to protect the results obtained from research or potential new business projects that are essential for the growth and development of organizations, both public and private.
PONS IP has organized numerous conferences to analyse the new Law key points. In this instance, together with Parc Cientific and in collaboration with Biocat, a conference was held in Barcelona, in which our expert in the matter, Amaya Mallea, Director of R & D+i Legal Consultancy at PONS IP will talk about the most relevant features of this new way of protecting knowledge and innovation.
Upcoming sessions scheduled:
- June 5th. Madrid Chamber of Commerce: Trade secrets
- June 13th. Universidad de Valladolid: Trade secrets
- June 24th. Universidad Autónoma de Barcelona: Trade secrets
Law Degree, Universidad Autónoma de Madrid. Master’s Degree in Copyright Law, Universidad Pontificia Comillas-ICADE.
Amaya is a lawyer with over 17 years of experience in Intellectual Property, particularly in Patent Law and Technology Transfer. She is an expert in negotiation and drafting of agreements (patent licenses, consortium agreements or research and development contracts, among others) and has extensive experience in the implementation of intangible asset management systems, as well as in the definition and execution of technology transfer processes.
Amaya Mallea works with domestic and international clients from different technological sectors, and usually provides legal advice to biotechnology companies, Universities and research centers and institutes.
Lecturer at “Course on Intellectual Property Law” from the Bar Association of Madrid (ICAM), at “Health Organizations Management Program” from the Instituto de Empresa (IE), on the LLM in Intellectual Property Law at Rey Juan Carlos University (Madrid), and regular speaker at law courses, seminars and conferences relating to Intellectual Property.
Enlaces de interés: